MM120 for Major Depressive Disorder
Do you struggle with depression? You are not alone. We are researching a new investigational treatment option to determine its effectiveness in treating depression. If you suffer from depression, you may be eligible to participate.
About This Clinical Trial
What is being tested? MM120 is a study drug that researchers believe could have possible benefits that may improve your depression symptoms.
Does it cost to participate? It does not cost anything to participate in the study. If you participate in the study, you will be compensated for travel and your time.
Why Clinical Trials? Participation in a clinical study can help researchers learn more and discover new treatments for the disease that is being studied. If you take part, other people with depression may be helped by the research.
What to Expect as a Trial Participant
- If you qualify for participation, you will receive either the study drug or placebo, which is an active drug that looks like the study drug but contains no active ingredients.
- There is a 40 week extension phase of the study where eligible participants can receive study drug.
- The study lasts approximately 56 weeks.
- You will attend in-person visits and remote visits throughout your participation.
- Taking part is completely voluntary and you may discontinue participation at any time.
Am I Eligible? Key Considerations
You may be eligible if you are:
- Aged 18 to 74 years old
- Experiencing depression
- Willing to use a highly effective method of birth control throughout participation
- Willing to stop all medications affecting mood
Ready to Take the Next Step?
Call for information on Psychedelic-Assisted Clinical Trials: 310-996-8966
Schedule a consultant and find out if participating in a clinical trial or other care option is right for you.
Crisis Support Disclaimer
Notice: If you or someone you know is in crisis, call the National Suicide Prevention Lifeline at 1-800-273-TALK (8255), or text the Crisis Text Line (text HELLO to 741741).